Progression of ataxia in patients with Machado‐Joseph disease
- 13 May 2009
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 24 (9) , 1387-1390
Abstract
Although ataxia is the most distressing manifestation of Machado‐Joseph disease (MJD), little is known about its natural history. Therefore, we prospectively followed a cohort of patients with MJD for 13 months to characterize the progression of ataxia and identify its contributory factors. The international cooperative ataxia rating scale (ICARS) was used to estimate severity of ataxia at baseline and at follow‐up. Thirty‐four patients were enrolled in the study, 22 of whom were men. Mean age at onset of the disease was 34.7 years and length of expanded CAG repeat was 66. Mean ICARS scores at baseline was 37.6 and at follow‐up was 42.7 (P < 0.001). Multivariate analysis did not find significant association of progression of disease and age at disease onset, length of expanded (CAG), or duration of disease. © 2009 Movement Disorder SocietyKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (04/13725-4)
This publication has 7 references indexed in Scilit:
- The international cooperative ataxia rating scale in Machado‐Joseph disease. Comparison with the unified multiple system atrophy rating scaleMovement Disorders, 2007
- Scale for the assessment and rating of ataxiaNeurology, 2006
- Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patientsMovement Disorders, 2006
- Neurologic Findings in Machado-Joseph DiseaseArchives of Neurology, 2001
- International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndromeJournal of the Neurological Sciences, 1997
- Correlations Between Triplet Repeat Expansion and Clinical Features in Huntington's DiseaseArchives of Neurology, 1995
- CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1Nature Genetics, 1994